|Bid||163.09 x 200|
|Ask||163.21 x 100|
|Day's Range||160.91 - 164.55|
|52 Week Range||71.46 - 167.00|
|PE Ratio (TTM)||227.89|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Zacks.com featured highlights: Vertex Pharmaceuticals, AGCO, Owens Corning, Five9 and Axcelis Technologies
IBD's 439-company Biotech industry group is now ranked fourth out of 197. How far can the rally go?
Impressive performance of Vertex Pharmaceuticals' (VRTX) cystic fibrosis drugs Kalydeco and Orkambi may drive the stock to an earnings beat in Q2.